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 Opinion Paper 
 Graham H.  Beastall * 
 Adding value to laboratory medicine: 
a professional responsibility 
 Abstract 
 Laboratory medicine is a medical specialty at the centre 
of healthcare. When used optimally laboratory medicine 
generates knowledge that can facilitate patient safety, 
improve patient outcomes, shorten patient journeys and 
lead to more cost-effective healthcare. Optimal use of 
laboratory medicine relies on dynamic and authoritative 
leadership outside as well as inside the laboratory. The 
first responsibility of the head of a clinical laboratory is 
to ensure the provision of a high quality service across 
a wide range of parameters culminating in laboratory 
accreditation against an international standard, such as 
ISO 15189. From that essential baseline the leadership of 
laboratory medicine at local, national and international 
level needs to  ‘ add value ’ to ensure the optimal delivery, 
use, development and evaluation of the services provided 
for individuals and for groups of patients. A convenient 
tool to illustrate added value is use of the mnemonic 
 ‘ SCIENCE ’ . This tool allows added value to be considered 
in seven domains: standar disation and harmonisation; 
clinical effectiveness; innovation; evidence-based prac-
tice; novel applications; cost-effectiveness; and educa-
tion of others. The  assessment of added value in labora-
tory medicine may be considered against a framework 
that comprises three dimensions: operational efficiency; 
patient management; and patient behaviours. The profes-
sion and the patient will benefit from sharing examples of 
adding value to laboratory medicine. 
 Keywords:  adding value;  clinical outcomes;  professional 
leadership. 
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 Introduction 
 Laboratory medicine data informs a high percentage of 
clinical decisions in healthcare. The percentage is often 
quoted as being approximately 70 %  [1] , although a more 
recent assessment suggests that the impact of laboratory 
medicine varies with the clinical specialty and application 
 [2] . What is beyond doubt is that laboratory medicine is an 
essential element of the healthcare system providing users 
with pivotal information for the prevent ion, diagnosis, 
treatment and management of health and disease  [3] . The 
global laboratory medicine market is expected to reach 
USD 52 billion in 2013  [4] and, although this is a large sum, 
it represents  < 5 % of total healthcare expenditure  [5] . 
 This central role of laboratory medicine in healthcare 
means that the leadership of the discipline has a respon-
sibility to ensure that it is used optimally to the benefit 
of the patient and the healthcare system. In this context 
leadership must include the director of local laboratory 
medicine services and also those in learned professional 
societies and other specialist laboratory medicine organi-
sations at a national and international level. 
 Assuring quality in laboratory 
medicine 
 The provision of a high quality laboratory medicine 
service is the primary responsibility of every professional 
working in the discipline. There are many definitions of a 
high quality laboratory medicine service; there is a vast 
literature on the subject; and there are organisations dedi-
cated to its practice and continuous development. One 
simple definition is  ‘ the establishment of conditions such 
that the quality of all tests performed in laboratory medi-
cine assists clinicians in practising good medicine ’  [6] . 
 Figure  1 summarises the components required to 
deliver a high quality laboratory medicine service. On 
the left hand side of this figure are the factors required 
to assure the quality of an individual test result or 
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investigation. On the right hand side are the parameters 
required by the laboratory to assure the quality of the sup-
porting infrastructure in the present and into the future. 
Central to the quality service is that it meets the needs of 
users as assessed through surveys of user satisfaction. The 
figure also reinforces that quality in laboratory medicine 
is the responsibility of everyone, not just of the laboratory 
director or quality manager. Finally, the central cog signi-
fies that high quality laboratory medicine is the essential 
engine to enable a value added service. 
 The most comprehensive measure of quality in lab-
oratory medicine is currently laboratory accreditation 
against an international standard. In Europe the current 
standard of choice is ISO 15189-2007  ‘ Medical laborato-
ries  – particular requirements for quality and compet-
ence ’  [7] . Accreditation of laboratories offering labora-
tory medicine services is now widespread across Europe 
although it is mandatory in only one country  [8] . Labora-
tory accreditation encompasses the  ‘ end to end ’ process 
from selecting and requesting an investigation to receiv-
ing a validated laboratory report that includes informa-
tion to assist with interpretation and knowledge that 
may be applied to individuals or to groups of patients. 
It is worthy of note that the very few errors that do occur 
in the laboratory medicine process are usually in either 
the preanalytical or postanalytical phases of the process 
 [9] where the laboratory medicine specialist tradition-
ally has had least influence. This important observation 
provides a valuable pointer to future role of laboratory 
medicine being increasingly outside the laboratory, 
adding value to the quality product produced within the 
laboratory. 
 Understanding added value in 
laboratory medicine 
 The concept of  ‘ added value ’ in Laboratory Medicine has 
existed for many years. The growing need for  ‘ clinical lab-
oratory consultants to add value and medical relevance to 
the healthcare system to earn and maintain their roles in 
an era of managed care ’ was described in 1995  [10] . This 
visionary publication focussed on a range of opportuni-
ties that look beyond the generation of an authorised 
laboratory report in order to ensure that the laboratory 
medicine service achieves optimal clinical relevance for 
users and that it takes advantage of rapid advances in 
technology and our understanding of the disease process 
and treatment opportunities. Panteghini concluded that 
 ‘ the importance and true impact of laboratory medicine 
can only be achieved by adding value to laboratory tests, 
represented by their effectiveness in influencing the man-
agement of patients and related clinical outcomes ’  [11] . 
 The rate of change in the scope, configuration, deliv-
ery and application of laboratory medicine has never 
been greater. Demand for laboratory medicine services is 
growing rapidly  [1] . This change and increased demand 
is happening at a time of financial pressure in healthcare 
across the developed world. Consequently, laboratory 
medicine specialists face the growing challenge of deliv-
ering a modern service that is both clinically efficient and 
cost-effective. This can only be addressed by  ‘ working 
smarter ’ – which includes eliminating waste, targeting 
clinical priorities, adopting automation and communica-
tion technology, altering the staff skill mix, networking 
services and sharing the costs with users. It is neither rea-
sonable nor desirable for laboratory medicine specialists 
to expect the users of the service to understand how to 
make the most effective use of a changing service. There-
fore, it must be the role of leaders in laboratory medicine 
to take responsibility for this process of knowledge man-
agement, education and support. This process consti-
tutes  ‘ adding value ’ to laboratory medicine. It is a process 
that should occur at local level between every laboratory 
medicine service and its users. It should also occur at a 
regional, national and international level to ensure that 
policy makers and those responsible for commissioning 
clinical services understand the pivotal role that labora-
tory medicine should play in a modern health service. 
Against this background this article seeks to provide a 
contemporary definition for  ‘ added value ’ and to intro-
duce a tool that will help laboratory medicine special-
ists appreciate where and how they can add value to the 
service that they provide. 
Availability
Appropriateness
Accuracy
Reproducibility
Timeliness
Clinical advice
Governance
Cost-effectiveness
Professional staff
Environment
Organisation
Equipment
Records
Audit
Development
Training/CPD
Quality 
management
Quality
Patient/user
satisfaction
The responsibility
of everyone in the lab 
 Figure 1   Assuring quality in laboratory medicine. 
 Parameters listed on the left of figure relate to the proper-
ties required of a test or investigation and the use of the result 
obtained. Parameters listed on the right relate to the requirements 
that need to be in place in order for a clinical laboratory to deliver a 
quality service. CPD, continuing professional development. 
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 The following definition of adding value to labora-
tory medicine is recommended:  ‘ The addition of value to 
 laboratory medicine services is the responsibility of lead-
ership in the speciality. It comprises working with users of 
the service and those responsible for defining and com-
missioning clinical services to ensure that the available 
high quality laboratory medicine services:
 –  Develop in line with contemporary knowledge and 
modern technology 
 –  Are evidence-based 
 –  Are cost-effective in the context of the patient journey 
and local targets 
 –  Facilitate improved clinical outcomes 
 –  Contribute to increasing patient safety 
 –  Are better understood by users, patients, the media 
and the wider public. ’ 
 Adding value to laboratory 
medicine through the appliance 
of  ‘ SCIENCE ’ 
 As the previous paragraph reveals the addition of value 
comprises several related dimensions. A simple tool has 
been developed to simplify understanding (Figure  2 ). 
 The mnemonic  ‘ SCIENCE ’ may be used to consider 
adding value in each of seven domains. Each of these 
domains will be considered in turn. It should be stressed 
that at the centre of this tool is the essential requirement 
for a high quality laboratory service, consistent with that 
delivered by an accredited laboratory. 
Standardisation/
harmonisation
Clinical-
effectiveness
Innovation
Evidence-based
practice
Education of
others
Cost-
effectiveness
Novel
applications
 Figure 2   Adding value to laboratory medicine through the appliance of  ‘ SCIENCE ’ . 
 The mnemonic  ‘ SCIENCE ’ describes the seven domains in which value can be added to a quality laboratory medicine service. The central cog 
refers to the high quality laboratory medicine service from Figure 1 that is necessary to drive added value. 
 Standardisation and harmonisation 
 Patients and the public are increasingly mobile and their 
clinical records may be accessed from wherever they are 
based. Therefore, laboratory medicine records should 
provide a consistent and coherent message. This is a 
matter of patient safety  [12] . Standardisation addresses 
the issue through conformance to an agreed standard. 
Harmonisation addresses the issue through consensus 
agreement where no standard exists. Within laboratory 
medicine there are active initiatives to standardise/har-
monise both practices and methods. 
 Laboratory medicine practices that may be standard-
ised include nomenclature and units of measurement  [13] . 
Practices that may be harmonised include reference intervals 
and action limits  [14] . Further harmonisation of investiga-
tive protocols is evidenced through the growing availabil-
ity of laboratory practice and clinical practice guidelines. 
Results from point of care testing (POCT) devices should be 
harmonised with those used by the central laboratory. 
 The standardisation and harmonisation of labora-
tory methods is an international partnership initiative 
involving laboratory medicine specialists together with 
scientists from the in vitro diagnostics industry. Method 
standardisation is a formal process that requires adher-
ence to metrological traceability  [15] . This has only been 
achieved for a relatively small number of biomarkers, 
which are listed by the Joint Committee for Traceability in 
Laboratory Medicine  [16] . A new international project has 
been proposed to address a co-ordinated approach to the 
harmonisation of the many methods that cannot meet the 
requirements of standardisation  [17] . 
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 Clinical-effectiveness 
 Laboratory medicine can make a major contribution to 
improving clinical effectiveness. This can be achieved 
through:
 –  The provision of direct patient care by medically 
qualified laboratory medicine specialists 
 –  The provision of rapid and accurate interpretive 
reports, which allow patients to be referred to the 
appropriate clinical team for further investigation 
and/or treatment, thus facilitating improved clinical 
outcomes 
 –  The provision of a clinical liaison advisory service 
 –  Participation in multidisciplinary clinical team 
meetings 
 –  Participation in clinical audit projects 
 –  The derivation and implementation of clinical prac-
tice guidelines.
There are many examples of laboratory medicine special-
ists taking the initiative to add value in order to deliver 
improved clinical effectiveness. These include the selec-
tion of clinical quality indicators  [18] , provision of inter-
pretative comments on reports to primary care physicians 
 [19] , critical value reporting  [20] , and reflective testing  [21] . 
In addition, the profession has introduced external quality 
assessment of the comments made on reports in an attempt 
to share good practice and achieve better agreement  [22] . 
 Innovation 
 Innovation has been at the heart of laboratory medicine for 
decades and it continues to be a dynamic driver of change. 
Advances in our understanding of the molecular basis of 
disease and the  ‘ omics ’ revolution are leading to many can-
didate biomarkers. Translation of original research find-
ings into clinical practice is challenging and a systematic 
approach is required to determine the accuracy and clini-
cal utility of new biomarkers  [23] . Advances in technology 
are meeting the demand for improved specificity (e.g., 
mass spectrometry), miniaturisation, more rapid turn-
around and self-monitoring by patients using POCT. 
 Innovation is also possible in the delivery of the lab-
oratory medicine service in an attempt to combine moder-
nisation with improved clinical and cost-effectiveness. 
Examples include developments in automation and robot-
ics, laboratory networking  [24] , shared technology and 
integrated diagnostics  [25] . 
 There is merit in coordinating innovation and in tar-
geting translational research funding. The UK National 
Health Service is supporting a number of initiatives to 
stimulate innovation in healthcare and transform good 
ideas into workable solutions. 
 Evidence-based practice 
 Evidence-based medicine comprises the distillation of 
research evidence, clinical expertise and patient values. 
The adoption of evidence-based medicine should facili-
tate consistent practice and improve clinical outcomes. 
Laboratory medicine specialists are trained to search and 
critically appraise the scientific and clinical literature 
and so are well placed to practice and contribute to the 
develop ment of evidence-based laboratory medicine  [26] . 
 Every laboratory medicine specialist should ensure 
that current laboratory practice and clinical practice 
guidelines are consistent with the latest evidence from the 
literature. This will involve acting as  ‘ knowledge manager ’ 
in discussions with users of the service. A proactive 
approach is required to ensure that laboratory medicine 
specialists are part of the multidisciplinary team that pre-
pares new evidence-based guidelines. Supporting litera-
ture is available to assist in this process  [27] . The Cochrane 
Library provides access to  > 5000 evidence-based reviews 
across healthcare  [28] . A wide range of evidence-based 
clinical practice guidelines are available, many of which 
include laboratory medicine investigations. One reputa-
ble source is the National Institute for Health and Clinical 
Excellence  [29] . 
 Novel applications 
 Until recently medicine was reactive, being population 
focussed, system-based and therapeutic. The patient 
has been a passive partner. However, we are now facing 
an exciting new direction as we move to medicine that is 
predictive, personalised, preventive and participatory (P4 
medicine)  [30] . This change of direction is based on indi-
vidual genome properties and so underpinned by modern 
molecular laboratory medicine. Pharmacogenomics is 
one established and growing area of P4 medicine and we 
are seeing the introduction of companion diagnostics in 
which the molecular diagnostic test is a prerequisite for 
selecting a patient for specific therapeutic drugs, notably 
in cancer  [31] . 
 The growth of P4 medicine presents a great opportu-
nity for laboratory medicine to reinforce our central role in 
healthcare. We will need to think of patients as individu-
als and in so doing the importance of reference intervals 
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and population-based action limits will diminish. We will 
need to think of wellness and risk stratification rather 
than disease. We will need to embrace a new range of 
methods and also the bioinformatics that will be essential 
to interpret complex data and algorithms from individual 
subjects. 
 Cost-effectiveness 
 The challenges presented by the need for the laboratory 
to be cost-effective tend to dominate thinking and are 
regarded by many specialists as a barrier to implementing 
the other domains of added value. However, all laboratory 
medicine specialists have a responsibility to deliver a cost-
effective service without compromising quality. There 
are three broad areas in which cost-effectiveness can be 
addressed. First, efforts can be made to contain or reduce 
the direct costs of running the laboratory. These include:
 –  The elimination of waste by using LEAN technology 
 [32] 
 –  Economies of scale from laboratory networking 
and the sharing of common equipment between 
laboratory specialties 
 –  Adjusting the skill mix of the staff to match the 
increasing automated technology.
Second, efforts can be made to reduce unnecessary testing 
through demand management and test request rationali-
sation. This is a topic of growing importance but it can 
be difficult to quantify its clinical and financial impact 
 [33] . In one well-controlled study a significant reduction 
in unnecessary testing was achieved through educational 
support for users  [34] .
Third, efforts can be made to adopt a more appropri-
ate business model. At present laboratory medicine is 
often regarded as a  ‘ production centre ’ with little or no 
link between output and clinical effectiveness. Inadequate 
reimbursement, fixed costs and silo budgeting all create an 
environment where it is difficult for laboratory medicine 
specialists to react to a rising workload and also bring in 
the added value that can make a difference to patients. A 
business model based on laboratory medicine as a  ‘ service 
centre ’ would be more appropriate with funding linked to 
the contribution to the care pathway  [35] . 
 Educating users and others 
 For many years laboratory medicine could be regarded 
as  ‘ the best kept secret in healthcare ’ . The profession 
has produced continuous quality improvement, intro-
duced high international standards of practice and suc-
ceeded in delivering a rapidly rising workload for little or 
no increase in costs. However, we are taken for granted 
by our many of our users and peers and largely unknown 
to the patient and the public. We have the image of being 
dominated by machines, which are kept running by a few 
 ‘ boffins ’ who work out of sight of the rest of the health-
care team. Recently, that situation has begun to change 
and one of the most important functions of the laboratory 
medicine specialist is to look outside the laboratory and 
actively promote the contribution of laboratory medicine 
to healthcare. 
 There are many ways in which the contribution of lab-
oratory medicine to healthcare may be promoted. These 
include:
 –  Providing evidence-based information in handbooks, 
publications and websites.  ‘ Lab Tests on Line ™ ’ is a 
shining example of what is possible  [36] 
 –  Participating in clinical audit, in multidisciplinary 
clinical team meetings and in groups responsible for 
writing clinical practice guidelines 
 –  Achieving greater contact with patients by visiting 
wards and clinics and by providing expert advice to 
patient organisations 
 –  Making a coordinated effort to engage with the media 
and the public. The National Pathology Year 2012 in 
the UK is a wonderful example of what is possible 
 [37] . 
 A framework for assessing the value 
of laboratory medicine 
 The assessment of the added value in laboratory medicine 
will vary according to the perspective of the person carry-
ing out the assessment. Thus, the healthcare manager or 
economist will try to answer the question  ‘ does it offer 
value for money ? ’ The physician will ask  ‘ will it improve 
the clinical outcome of the patient ? ’ The patient will con-
sider  ‘ will it help to resolve my problem in a speedier or 
less invasive way ? ’ Accordingly, a framework has been 
proposed for the assessment of the value of any develop-
ment in laboratory medicine across three dimensions  [38] . 
 Optimisation of operational efficiencies 
 Operational efficiency relates to the ability of a labo-
ratory to provide rapid results and reports which may 
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affect the further investigation, management or dis-
charge of the patient. Automated laboratory instru-
ments that improve workflow, informatics solutions 
that allow test results to rapidly reach physicians and 
middleware applications that reduce medical errors and 
improve turnaround time are all aspects of laboratory 
medicine that may contribute to operational efficien-
cies. Criteria that may be used to assess operational effi-
ciency include:
 –  Efficient patient triage 
 –  Patient waiting times and the length of the patient 
journey 
 –  The rate of re-investigation and re-admission 
 –  Operational costs. 
 Optimisation of patient management 
 The optimisation of patient management will depend to 
a large extent on the laboratory providing an interpre-
tive service that enables that laboratory information to be 
converted into knowledge for the benefit of the individual 
patient or groups of patients. The early deployment of an 
appropriate diagnostic test, the use of evidence-based 
clinical practice guidelines and the effective application 
of clinical audit are examples of how laboratory medicine 
can contribute to the optimisation of patient manage-
ment. Criteria that may be used to assess operational effi-
ciency include:
 –  Reduction in unnecessary investigation and 
treatment 
 –  Reduction in time taken and money spent on patient 
investigation 
 –  Improved patient outcome and/or improved quality 
of life. 
 Influence on patient behaviour and other 
effects 
 This dimension refers to the ability of laboratory medi-
cine to provide information to patients that will lead 
them to make different lifestyle choices or change their 
sense of satisfaction and well-being  [39] . Alteration 
of diet or exercise; the use of prophylactic medicines; 
self-monitoring; and planning for retirement may all be 
affected by a patient knowing the result of an investi-
gation that highlights present or future risk of disease. 
Criteria that may be used to assess operational effi-
ciency include:
 –  Evidence of patient empowerment 
 –  Information leading to a sense of satisfaction or 
well-being 
 –  Evidence of lifestyle management.
Using this simple framework any value that laboratory 
medicine can add may be assessed. Most developments 
are likely to add value to more than one of these three 
dimensions  [38] . For example, the introduction of a clini-
cally validated new biomarker will influence patient man-
agement and if it reduces the need for other investigations 
it is also likely to facilitate operational efficiency. Alter-
natively, patient self-monitoring for chronic disease using 
POCT will influence patient behaviour and should lead 
to better patient management. Depending on the costing 
model in place the use of POCT may also influence opera-
tional efficiency. 
 Conclusions 
 In nations with developed healthcare systems laboratory 
medicine specialists have been at the forefront of deliver-
ing services of the highest quality and they have been 
proud to embrace external accreditation. In achieving 
this status they have focussed on what goes on inside the 
laboratory. The time is now right for laboratory medicine 
specialists to also look outside the laboratory as part of 
the multidisciplinary team that seeks to optimise clini-
cal outcomes and patient experiences in an efficient and 
cost-effective way. As this article describes this process of 
adding value to laboratory medicine may be considered in 
a logical and convenient manner. A mechanism is required 
to share examples of added value and good practice. 
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